Skip to content

Clinical trials

Phase 3 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 3 Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
20033
20041
20052
20062
20071
20083
20095
20101
20116
20124
20133
20146
20152
20163
20174
201810
20194
20203
20216
20224
20234
202511
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated14
Recruiting10
Active, not recruiting9
Unknown status9
Withdrawn2
Not yet recruiting2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Eisai Inc.3
Hoffmann-La Roche3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Novartis3
Bristol-Myers Squibb2
Eisai Co., Ltd.2
GE Healthcare2
Janssen Pharmaceutical K.K.2
M. Schaefer, MD2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction100
Alzheimer Disease40
Dementia27
Memory Disorders7
Mental Disorders7
Nervous System Diseases7
Schizophrenia6
Central Nervous System Diseases5
Delirium5
Neurodegenerative Diseases5

Trials

Showing 26 to 50 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.